Please assess the completion status of the following clinical trial:

Trial Title: Alfuzosin Versus Placebo in Acute Urinary Retention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Men with acute urinary retention and catheterized~* Benign hypertrophia of prostate~* Patient is diagnosed in Emergency room or at a acute hospitalization~Exclusion Criteria:~* Known prostate cancer~* Prior urinary retention within 30 days~* Urinary retention occurring in relation to surgery~* Blood in urine~* Difficult or impossible catheterization~* Fever \> 38 degree Celsius~* Decreased kidney function~* Permanent catheter \> 14 days~* Treatment with alfa 1 blocker within 30 days~* Meeting contraindications to treatment with Alfuzosin~* Treatment with other drugs for urinary problems~The above information is not intended to contain all considerations relevant to a patients potential participation in a clinical trial.

- Gender: MALE
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).